ENTX vs. BBOT

Last updated Aug 1, 2026

ENTX (Entera Bio Ltd) and BBOT (BridgeBio Oncology Therapeutics, Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Their 0.20 correlation means their historical movements had little consistent relationship.

Performance

ENTX vs. BBOT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Entera Bio Ltd (ENTX) and BridgeBio Oncology Therapeutics, Inc (BBOT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ENTX achieves a 54.12% return, which is significantly higher than BBOT's -35.38% return.

ENTX

• 1D: 1.36%
• 1M: 80.12%
• 6M: 118.25%
• YTD: 54.12%
• 1Y: 53.33%
• 3Y*: 55.19%
• 5Y*: -10.27%
• 10Y*: —
• ALL TIME*: -10.45%

BBOT

• 1D: -4.82%
• 1M: -0.25%
• 6M: -30.97%
• YTD: -35.38%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
BBOT BridgeBio Oncology Therapeutics, Inc	$2.40M	$3.07M	$3.39M
ENTX Entera Bio Ltd	$35.47M	$17.12M	$7.21M

ENTX vs. BBOT - Yearly Performance Comparison

	2026 (YTD)	2025
ENTX Entera Bio Ltd	54.12%	3.19%
BBOT BridgeBio Oncology Therapeutics, Inc	-35.38%	22.75%

Correlation

The correlation between ENTX and BBOT is 0.20, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (All Time) Calculated using the full available price history since Aug 12, 2025	0.20

Fundamentals

Market Cap ENTX : $147.38M BBOT : $648.07M
EPS ENTX : -$0.11 BBOT : -$3.43
Total Revenue (TTM) ENTX : $0.00 BBOT : $0.00
Gross Profit (TTM) ENTX : -$15.00K BBOT : -$194.00K
EBITDA (TTM) ENTX : -$12.42M BBOT : -$168.31M

Return for Risk

ENTX vs. BBOT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ENTX

ENTX Risk / Return Rank: 67
ENTX Sharpe Ratio Rank: 61
ENTX Sortino Ratio Rank: 78
ENTX Omega Ratio Rank: 73
ENTX Calmar Ratio Rank: 64
ENTX Martin Ratio Rank: 59

BBOT

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ENTX vs. BBOT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Entera Bio Ltd (ENTX) and BridgeBio Oncology Therapeutics, Inc (BBOT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ENTX	BBOT	Difference
Sharpe ratio: Return per unit of total volatility	0.43	—	—
Sortino ratio: Return per unit of downside risk	1.94	—	—
Omega ratio: Gain probability vs. loss probability	1.21	—	—
Calmar ratio: Return relative to maximum drawdown	0.81	—	—
Martin ratio: Return relative to average drawdown	1.25	—	—

Drawdowns

ENTX vs. BBOT - Drawdown Comparison

The maximum ENTX drawdown since its inception was -93.15%, which is greater than BBOT's maximum drawdown of -48.14%. Use the drawdown chart below to compare losses from any high point for ENTX and BBOT.

Drawdown Indicators

	ENTX	BBOT	Difference
Max Drawdown Largest peak-to-trough decline	-93.15%	-48.14%	-45.01%
Max Drawdown (1Y) Largest decline over 1 year	-68.15%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-68.15%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-91.26%	—	—
Current Drawdown Current decline from peak	-59.04%	-41.08%	-17.96%
Average Drawdown Average peak-to-trough decline	-68.20%	-22.63%	-45.57%
Ulcer Index Depth and duration of drawdowns from previous peaks	44.00%	—	—

Volatility

Volatility by Period

	ENTX	BBOT	Difference
Volatility (1M) Calculated over the trailing 1-month period	70.79%	—	—
Volatility (6M) Calculated over the trailing 6-month period	97.26%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	128.59%	69.10%	+59.49%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	96.95%	69.10%	+27.85%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	114.64%	69.10%	+45.54%

Dividends

ENTX vs. BBOT - Dividend Comparison

Neither ENTX nor BBOT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ENTX and BBOT in my portfolio?

ENTX and BBOT have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.